Log in or Sign up for Free to view tailored content for your specialty!
Oncology News
Bulk ordering, text messaging improve mammography completion rates
Bulk ordering and text messaging outreach significantly increased completion rates for mammography breast cancer screening, according to results of two randomized clinical trials published in JAMA Internal Medicine.
PCPs tied to cervical cancer screening adherence, regardless of sexual orientation
Having a primary care provider raises the likelihood of being up to date on cervical cancer screening, regardless of sexual orientation, but the association was greatest among lesbian, gay and bisexual women, according to researchers.
Log in or Sign up for Free to view tailored content for your specialty!
Increased childhood leukemia risk with embryo transfer vs. natural conception
Children conceived via fresh or frozen embryo transfer may have increased risk for acute lymphoblastic leukemia compared with children conceived naturally, according to cohort study results published in JAMA Network Open.
FDA approves Hercessi as latest interchangeable Herceptin biosimilar
The FDA has approved trastuzumab-strf as a biosimilar to trastuzumab for the treatment of certain patients with HER2-overexpressing malignancies, according to a press release from the agent’s manufacturer.
USPSTF: Women should be screened for breast cancer every other year starting at age 40
Women should be screened for breast cancer every other year starting at age 40 years, according to a new recommendation statement from the U.S. Preventive Services Task Force.
Tool may predict premature menopause among childhood cancer survivors
A multi-institutional team of researchers created a statistical model capable of predicting the risk for premature menopause among women who survived childhood cancer.
Enhertu delays disease progression in certain patients with metastatic breast cancer
Compared with standard-of-care chemotherapy, trastuzumab deruxtecan demonstrated a statistically significant improvement in PFS among certain patients with metastatic breast cancer, according to a press release from the manufacturer.
‘Disappointing’ data confirm aspirin does not reduce risk for breast cancer relapse
Daily aspirin use did not reduce disease recurrence, progression or mortality in patients with high-risk breast cancer, according to extended follow-up results of a terminated study published in JAMA.
Increased mortality risk for BRCA carriers diagnosed within 10 years postpartum
Women with breast cancer and germline BRCA pathogenic variants had increased all-cause mortality risk if diagnosis occurred within 10 years postpartum, according to cohort study results published in JAMA Network Open.
Neighborhood disadvantage linked to shorter breast cancer-specific, overall survival
Women with breast cancer living in the most vs. the least disadvantaged neighborhoods had higher risks for breast cancer-specific and overall mortality, according to cohort study results published in JAMA Network Open.
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read